# DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder

> **NCT02623504** · PHASE4 · TERMINATED · sponsor: **Validus Pharmaceuticals** · enrollment: 17 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Carbamazepine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02623504
- **Lead sponsor:** Validus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-10-24
- **Primary completion:** 2018-11-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** No apparent therapeutic effects that was superior to placebo
- **Last updated:** 2023-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02623504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02623504, "DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02623504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*